Screener
Corcept Therapeutics CORT Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use asset | 6,860 | 4,583 |
| Property and equipment, net | 5,133 | 1,890 |
| Long-term marketable securities | 236,451 | 160,270 |
| Other assets | 2,946 | 5,153 |
| Deferred tax assets, net | 178,680 | 168,197 |
| Total assets | $888,702 | $836,651 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's other non-current assets?
- Corcept Therapeutics (CORT) reported other non-current assets of $2.95M in Q2 2026.
- How has Corcept Therapeutics's other non-current assets changed year-over-year?
- Corcept Therapeutics's other non-current assets decreased by 64.5% year-over-year, from $8.3M to $2.95M.
- What is the long-term trend for Corcept Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's other non-current assets has grown at a 0.6% compound annual growth rate (CAGR), from $5M to $5.15M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Corcept Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude